What type of study is this?

Influence of social determinants of health (SDoH) on metastatic non-small cell lung cancer (mNSCLC) testing in the community setting.

View Full Paper

Ask AI

Bookmark

Authors

Observational analysis uncovers lower biomarker testing rates in early-stage lung cancer patients, highlighting social determinants' influence.

Patients diagnosed with early-stage NSCLC were significantly less likely to receive biomarker testing.
Out of 1,000 patients, 51.2% identified as female and 75.9% as White, with many exhibiting missing data.
Natural language processing was employed to confirm biomarker testing across varied patient cohorts and demographics.
Older patients and those diagnosed pre-2020 showed lower rates of testing, indicating significant barriers influenced by social determinants.

Florez et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Observational analysis uncovers lower biomarker testing rates in early-stage lung cancer patients, highlighting social determinants' influence.